Truist Securities Maintains Buy on Ovintiv, Raises Price Target to $77

Truist Securities analyst Gabe Daoud has maintained a 'Buy' rating on Ovintiv (NYSE: OVV) and increased the price target from $73 to $77. This adjustment reflects a positive outlook for the company's stock performance.